EPFB
XBI icon

Employees Provident Fund Board’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Employees Provident Fund Board’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-721,768
Closed -$60.1M – 89
2023
Q2 		$60.1M Buy
721,768
+192,777
+36% +$16.1M 1.42% 33
2023
Q1 		$40.3M Buy
+528,991
New +$43.9M 1.04% 38

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Employees Provident Fund Board's XBI Position: Q3 2023 in Review

Employees Provident Fund Board sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 721,768 shares — an estimated $60.1M sold.

Employees Provident Fund Board first reported a position in XBI in Q1 2023 and held it in 2 quarters. The position peaked at $60.1M in Q2 2023. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

  • Employees Provident Fund Board reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • Employees Provident Fund Board sold 721,768 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $60.1M.
  • Employees Provident Fund Board first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 2 quarters.
  • Employees Provident Fund Board's State Street SPDR S&P Biotech ETF position peaked at $60.1M in Q2 2023.
  • 679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Employees Provident Fund Board's 13F filing for Q3 2023, filed 18 Mar 2026.